RE:RE:RE:RE:RE:RE:RE:RE:Pfizer response to questions on M&A -> add value to companyAs of June 30, 2022 Pfizer reported a revenue increase of $20.0 billion, or 60%, in the first six months of 2022 to $53.4 billion from $33.4 billion in the first six months of 2021, reflecting an operational increase of $22.0 billion, or 66% from the same time last year.
Pfiser has plenty enough cash on hand for an ONCY acquisition.